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Mucosal lymphocytes support latent infections of species C adenoviruses. Because infected lymphocytes
resist re-infection with adenovirus, we sought to identify changes in cellular gene expression that could
inhibit the infectious process. The expression of over 30,000 genes was evaluated by microarray in
persistently infected B-and T-lymphocytic cells. BBS9, BNIP3, BTG3, CXADR, SLFN11 and SPARCL1 were the
only genes differentially expressed between mock and infected B cells. Most of these genes are associated
with oncogenesis or cancer progression. Histone deacetylase and DNA methyltransferase inhibitors
released the repression of some of these genes. Cellular and viral gene expression was compared among
leukemic cell lines following adenovirus infection. Childhood leukemic B-cell lines resist adenovirus
infection and also show reduced expression of CXADR and SPARCL. Thus adenovirus induces limited
changes to infected B-cell lines that are similar to changes observed in childhood leukemic cell lines.
& 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Background
Species C adenoviruses infect most people asymptomatically in the
ﬁrst few years of life (Garnett et al., 2002, 2009), and appear to be the
most common prenatal viral infection in humans as well (Baschat et al.,
2003; Ornelles et al., 2015; Reddy et al., 2005; Wenstrom et al., 1998).
These viruses establish long-term, perhaps life-long, latent infections of
mucosal lymphocytes as evidenced by the observation of intermittent
virus shedding in stool (Fox et al., 1977), and that activation of non-
virus-producing tonsil lymphocytes in vitro results in infectious virus
production from most individuals (Garnett et al., 2009).
Experimental infections of human T-cell and B-cell leukemia cell
lines were used to model the characteristics of adenovirus latency
(Zhang et al., 2010). Some of these lymphocyte cells support vigorous
adenovirus replication while maintaining nearly normal levels of cell
division, in sharp contrast to the rapid cytolytic effect seen in infec-
tion of epithelial cells. Following initial infection, some lymphocyteInc. This is an open access article u
ia State University, 161 Jesse
ett-Benson).cell lines gradually lose expression of viral genes while maintaining
the quiescent viral genome for weeks or months with minimal virus
replication detected in the cultures, suggesting a latent state (Zhang
et al., 2010). Signiﬁcantly, expression of the virus receptor (CAR) is
lost on the cell surface at late times of infection. Loss of CAR late in
infection of lymphocytes is due to absence of CAR mRNA expression
(Zhang et al., 2010), suggesting that adenovirus infection elicits long-
lasting changes in cellular gene expression by an epigenetic
mechanism. Reestablishing CAR expression in persistently infected
cells did not restore infectivity, indicating that cellular changes in
addition to down-regulation of the viral receptor have occurred.
These changes render the cells refractory to adenovirus infection.
At present, alteration in cellular gene expression in virus latency
is best understood among the herpesviruses. For example the
analysis of gene expression by oligonucleotide or cDNA arrays in
models of human cytomegalovirus (HCMV) and Epstein Barr Virus
(EBV) latency found dozens and hundreds of cellular genes
respectively whose expression is modiﬁed compared to uninfected
cells (Homa et al., 2013; Slobedman et al., 2004). These studies
suggest that many cellular genes are altered by these viruses to
produce an intracellular environment conducive to the main-
tenance of latency. In the present study we assessed alterations innder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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technology in models of adenovirus latency in lymphocytes to
determine the extent to which cellular gene regulation is occurring
in long-term infected cells.
Adenoviruses are the most frequently detected viruses in human
cord blood (Ornelles et al., 2015; Reddy et al., 2005; Wenstrom et
al., 1998). We, and others, have previously speculated that these
viruses are candidates for producing the initiating event leading to
the development of childhood acute leukemias (Heath, 2005;
Hughes et al., 2007; McNally and Eden, 2004). The absence of
adenoviral genetic material in leukemic cells suggests a potential
hit-and-run mechanism by which the virus permanently alters
some cellular function before being itself ejected from the cell.
Using the Affymetrix U133 chip set, we determined that the
expression of only six cellular genes is altered in infected B cells. We
extended the analysis to include evaluation of the expression of the
viral-modulated genes in cell lines of adult and childhood leuke-
mias. Two of these six genes are signiﬁcantly suppressed in cell
lines of childhood leukemia origin but not in those of adult origin.
Further, we found that the virus achieved durable changes in the
expression of many of these genes by epigenetic mechanisms.2. Materials and methods
2.1. Cell lines
BJAB cells are an EBV-negative B cell line that was established in
1975 from an African case of Burkitt's lymphoma. The patient from
whose tumor the original BJAB line was established was ser-
opositive for EBV antigens although the tumor was not infected
with EBV. BJAB cells were reported to have a normal karyotype at
the time of establishment (Clements et al., 1975). KE37 cells are a T
cell leukemia cell line established from an acute lymphoblastic
leukemia patient in 1979. The cell line used for this study was
obtained from the German Collection of Microorganisms and Cell
Cultures (DSMZ, Braunschweig). Cytogenetic analysis indicated a
pseudodiploid karyotype with 12% polyploidy. The karyotype was
described as: 46(43-46)o2 n4X,-Y,þmar, t(8;9)(p11;p24), der(18)
t(X;18)(p11;q11) (Romano et al., 2009). Additional cell lines used for
short term experiments were B cell lines derived from childhood
and adult leukemias. The following cell lines were derived from
childhood ALL: REH, UoC-B4, RS4;11, SEM, EU-8, KOPN-8, RCH-ACV,
and 697 (EU-3). The following cell lines were derived from adult B-
cell lymphomas, leukemias or EBV transformed cells: ARH77,
Ramos, RPMI-1788, SB, and Raji. ARH77, Raji, Ramos, REH, RPMI-
1788, RS4;11 cells were obtained from ATCC. BJAB cells were ori-
ginally obtained from Ken Takemoto (Klein et al., 1974) and SB cells
were obtained from Chas Yang. EU3, EU8 and UoCB4 were obtained
from Harry Findley (Zhou et al., 1995). The remaining cell lines,
KOPN-8, RSH-ACV and KE37 were obtained from the DSMZ in
Germany. RS4;11 CAR-hi were generated by transducing an isolate
of RS4-;11 cells with a CAR-expression retrovirus, as previously
reported (McNees et al., 2004; Zhang et al., 2010). Cell lines were
maintained in the recommend growth medium supplemented with
fetal bovine serum. Cells were incubated at 37 °C incubator with 5%
CO2 and tested to ensure absence of Mycoplasma.
2.2. Infection of lymphocyte cell lines
Ad5dl309 is an Ad5 mutant that lacks the genes for E3 RIDα
and RIDβ proteins and for the 14,700-molecular-weight protein
(14.7 K protein) and was used as the virus for these experiments.
Lymphocytes were collected and washed in serum-free medium.
Cell density was adjusted to 107 cells per ml in serum-free med-
ium. Virus (dl309) was added to the cell suspension at 100infectious units (deﬁned on A549 cells) per cell and incubated at
37 °C for 3 h. The infected cells were washed three times with
complete growth medium and then resuspended and maintained
in complete growth medium at 5105 cells per ml.
2.3. Chronic virus infection
BJAB and KE37 cells were infected with the phenotypically
wild-type virus dl309 to establish uniformly infected cells. Six
independently infected cell lines (three each of BJAB and KE37)
were generated. The infected cells were maintained under stan-
dard growth conditions ranging between 51 and 78 days. Non-
infected cells were maintained as six independent cultures for
similar lengths of time. Immediately before isolating RNA from the
cell lines, hexon expression was measured by immunoﬂuorescence
and ﬂow cytometry (Garnett et al., 2009). The presence of ade-
novirus DNA in each cell was conﬁrmed by limiting dilution fol-
lowed by a nested PCR for adenovirus DNA as described in (Gar-
nett et al., 2009). The average amount of adenovirus DNA per cell
was determined by quantitative PCR of the hexon gene.
2.4. Analysis of RNA levels by microarray
Total cellular RNA was isolated from 106 to 107 lymphocytes
using the Qiagen RNeasy puriﬁcation kit. The integrity of the pur-
iﬁed RNA was veriﬁed by the Microarray Core Lab of the Compre-
hensive Cancer Center of Wake Forest University and used to query
the Affymetrix Human Genome U133 Plus 2.0 array which contains
54,675 oligonucleotide probes permitting analysis of 47,000 tran-
scripts from 38,500 human genes. The resulting expression data
were analyzed with the open source tools available through the
Bioconductor (Gentleman et al., 2004). Expression data were
adjusted and normalized by different approaches provided by the
Affymetrix and GCRMA packages and by the systematic variation
normalization (SVN) method developed by Chou et al. (2007). The
limma package was used to perform statistical analysis and assess
differential expression of the normalized expression data. The
limma package implements an empirical Bayes method to moder-
ate the standard errors of the change in expression level and pro-
vides tools to identify signiﬁcant differences. Raw expression data
was adjusted and normalized by the algorithms implemented in the
Affymetrix MicroArray Suite 5.0 (MAS5), RMA, GCRMA, and SVN
packages. Normalization performed by MAS5 determines a baseline
expression level for 100 “housekeeping” genes. The MAS5 algorithm
normalizes values for abundantly expressed genes very well but is
less efﬁcient for genes that are less abundant. The RMA algorithm
computes a robust multi-array average of expression values by
background adjustment, quantile normalization among arrays, and
summarization. The key property of RMA is the adjustment of the
quantile-quantile plot among all arrays to achieve normalization
(Irizarry et al., 2003). GCRMA uses a similar algorithm to the RMA
method but models probe afﬁnity for perfect match and mismatch
oligos in the Affymetrix probe sets in order to perform a more
aggressive background correction. The systematic variation nor-
malization (SVN) method of Chou (Chou et al., 2007) performs
background subtraction determined by the distribution of pixel
intensity values, then linear or non-linear regression, transforma-
tion and multi-array normalization to remove systematic variation
across multiple array experiments. The SVN algorithm requires
fewer regression parameters to normalize the preprocessed data
than either the RMA or GCRMA methods. Normalized data were
analyzed by a linear modeling approach where the four groups
being analyzed were BJAB-mock, BJAB-virus, KE37-mock and KE37-
virus. Comparisons between BJAB-mock vs. BJAB-virus, KE37-mock
vs. KE37-virus and BJAB-mock vs. KE37-mock were performed by
linear modeling. The empirical Bayes method was used to adjust the
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individual variances from the population on the whole. To perform
this adjustment and to calculate a moderated t-statistic or false-
discovery rate, the proportion of differentially expressed genes (a
priori probability) was assumed to be 0.3% or about 150 genes.
2.5. Analysis of RNA levels by real-time quantitative PCR
Puriﬁed RNA was treated with Rnase-free DNase (Qiagen Inc.
Valencia, CA), quantiﬁed and 200 ng were reverse transcribed (RT)
into cDNA in 20 uL reaction volumes using Maxima First Strand cDNA
Synthesis Kit for RT-qPCR (Thermo Scientiﬁc). RT-enzyme negative
controls were included for each reaction. Predesigned primers and
probes (PrimeTime) were obtained from Integrated DNA Technolo-
gies (Coralville, IA). Primer and probe sequences are reported in
Table 1. Probes were labeled at the 50 end with 6-carboxyﬂuorescein
(FAM) reporter molecule and contained dual ZEN and Iowa Black
quenchers. The RT-qPCR assay was performed in 25 μL using 2X
TaqMan Gene Expression Master Mix (Applied Biosystems) with
1 nmole of each primer, 0.5 nmole probe, and 2.5 μL of cDNA product
obtained from the RT reaction. The ampliﬁcation for each sample was
performed in duplicate wells using a standard PCR thermal cycling
condition was 50 °C for 2 min, 95 °C for 10 min, 40 cycles of 95 °C for
15 sec and 60 °C for 1 min using a 7500 Real Time PCR System
(Applied Biosystems). Analysis of relative gene expression in infected
BJAB cells was determined using real-time quantitative PCR and the
ΔΔCt method (Livak and Schmittgen, 2001).
Relative mRNA levels were determined by a modiﬁcation of the
ΔΔCt method. In some experiments, mRNA for CXADR and SPARCL1
could not be detected in the childhood leukemic cell lines. For these
cases, the Ct was set to a limiting value of 40. Ct values were ﬁrst
normalized to the housekeeping gene (CD44, EIF1 or GAPDH)
within each of nine PCR experiments (ΔCt). Values were further
normalized to the mean value of all adult-derived cell lines in the
experiment (ARH77, Ramos, Raji and BJAB). These twice-normalized
values (ΔΔCt) were further analyzed by the t-test in order to
determine if the mean level for each gene in the childhoodTable 1
Primer-probe sequences.
Gene symbol Gene name
BTG3 BTG family, member 3
BTG3 BTG family, member 3
BTG3 BTG family, member 3
CXADR coxsackie virus and adenovirus receptor
CXADR coxsackie virus and adenovirus receptor
CXADR coxsackie virus and adenovirus receptor
SPARCL1 SPARC-like 1 (hevin)
SPARCL1 SPARC-like 1 (hevin)
SPARCL1 SPARC-like 1 (hevin)
BNIP3 BCL2/adenovirus E1B 19 kDa interacting protein 3
BNIP3 BCL2/adenovirus E1B 19 kDa interacting protein 3
BNIP3 BCL2/adenovirus E1B 19 kDa interacting protein 3
SLFN11 schlafen family member 11
SLFN11 schlafen family member 11
SLFN11 schlafen family member 11
BBS9 Bardet-Biedl syndrome 9
BBS9 Bardet-Biedl syndrome 9
BBS9 Bardet-Biedl syndrome 9
CD44 CD44 molecule (Indian blood group)
CD44 CD44 molecule (Indian blood group)
CD44 CD44 molecule (Indian blood group)
EIF1 eukaryotic translation initiation factor 1
EIF1 eukaryotic translation initiation factor 1
EIF1 eukaryotic translation initiation factor 1
GAPDH glyceraldehyde-3-phosphate dehydrogenase
GAPDH glyceraldehyde-3-phosphate dehydrogenase
GAPDH glyceraldehyde-3-phosphate dehydrogenaseleukemic cell lines was signiﬁcantly different from 0 (log of 1). A p-
value less than 0.05 was considered signiﬁcant. Because the Ct
measured for CXADR and SPARCL1 was assigned a limiting value in
certain cases, the associated p-values must be considered an
estimate.2.6. Analysis of coordinate regulation by EPIG
Patterns of coordinately expressed genes were identiﬁed by the
method of Chou known as “extracting gene expression patterns
and identifying coexpressed genes” or EPIG (Chou et al., 2007). For
this analysis, gene expression within each data set was repre-
sented as the log2 ratio of sample to reference or signal. The
average signal of each probe from mock-infected cells was set to
zero in order to determine the relative level of gene expression in
virus-infected cells. An iterative process using Pearson's correla-
tion coefﬁcient, the magnitude of the signal and the signal-to-
noise ratio was used to extract groups of coordinately expressed
genes as described (Chou et al., 2007).
2.7. Functional analysis of coordinately regulated genes
Genes that showed a common pattern by the EPIG analysis
were evaluated with the Functional Annotation Clustering tool of
the Database for Annotation, Visualization and Integrated Dis-
covery (DAVID), version 6.7 http://david.abcc.ncifcrf.gov. Default
settings were chosen with the exception of more stringent
enrichment threshold (EASE score) of 0.05. The EASE score of each
group is derived from the geometric mean of the modiﬁed Fisher
exact p-value associated with the enriched annotation terms that
belong to the group. The group enrichment score provides a
measure of relative importance of the gene groups with higher
enrichment scores indicating more signiﬁcant enrichment. The
relative enrichment for a given group of genes was tabulated
against the possible genes represented on the Affymetrix Human
133 Plus 2 Array.Oligo Sequence
Primer 1 GCTTTCAGGACATCAGGATCA
Primer 2 CAGTTGAGAGGTTTGCTGAGA
Probe TCTGAAATTTATTGACACGAATACATCTGTAGGCC
Primer 1 GGCTTTTTCAATCATCTCTTCAGG
Primer 2 TGCTGTGCTTCGTGCTC
Probe AACTTCTGGCGAAATCCACTACTCCG
primer1 GATCCTTCAATCCCAGCTCTT
primer2 CAGCAGTATCCACAGAAGACG
probe AGCCATGAACAGTCAGCAGAACAGG
primer1 TGTTGGTATCTTGTGGTGTCTG
primer2 GCATGAGTCTGGACGGAGTA
probe CTCACTGTGACAGCCCACCTCG
primer1 TGTTCCAGGCCTTTCTTGG
primer2 GATGACAGACACAGATCCAGAT
probe CCTCCCCTTAGCAGACCAGTGT
primer1 GCACGTAGACTGATAATTTGGC
primer2 ACTGACCTTGTCCCTTCTGT
probe ACTCTGTTCTGCAGTGTGACCTTCAC
primer1 TCCAAATCTTCCACCAAACCT
primer2 TCTTCAACCCAATCTCACACC
probe ACGCTTCAGCCTACTGCAAATCCA
primer1 GATATAATCCTCAGTGCCAGCA
primer2 GTATCGTATGTCCGCTATCCAG
probe CTCCACTCTTTCGACCCCTTTGCT
primer1 TGTAGTTGAGGTCAATGAAGGG
primer2 ACATCGCTCAGACACCATG
probe AAGGTCGGAGTCAACGGATTTGGTC
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Cells were cultured in 24-well plates at a concentration of 106
cells per mL prior to treatment. TSA (Trichostatin A, Sigma-
Aldrich), a histone deacetylase inhibitor, was used at a con-
centration of 50 nM for UOC-B4 cells, and 300 nM for all other cell
lines. 5-Aza (5-Aza-20-deoxycytidine, Sigma-Aldrich), a DNA
methyltransferase inhibitor, was used at a concentration of 10 uM.
Cells were incubated alone, with TSA, or with 5-Aza for 48 h.
Viability of cells was determined by Trypan blue dye-exclusion
using a hemocytometer.3. Results and discussion
3.1. Persistently infected lymphocytes show limited changes in gene
expression
Several human lymphocytic cell lines support long-term adeno-
viral infections and proliferate at the same rate as non-infected cells
(Zhang et al., 2010). Some of these cell lines can maintain the viral
genome for more than a year in culture. Within 24 h post-infection
the cells lose expression of the coxsackie and adenovirus receptor
(CAR) on their surface and this loss is maintained for more than 100
days following infection. The immediate loss of surface CAR on
infected cells is facilitated by viral ﬁber and is followed by the
absence of CXADR mRNA beginning around 30 days post-infection.
Because enforced expression of CAR was not sufﬁcient to revert once-
infected cells into becoming susceptible to a secondary infectionwith
the virus (Zhang et al., 2010), we reasoned that other genes are stably
altered following infection of lymphocytic cells.
One B-cell line (BJAB) and one T-cell line (KE37) were evaluated
for global changes in gene expression approximately two months
post-infection. Greater than 90% of the cells were infected at the
start of the experiment and a limiting dilution assay determined
that the viral genome was maintained in over two-thirds of theFig. 1. Relative levels of gene expression in infected and non-infected KE37 and BJAB cell
indicated in Fig. 1 and described in the Materials and Methods. An empirical Bayes met
where the proportion of differentially expressed genes (a priori probability) was assumed
the odds ratio for differentially expressed genes in virus-infected cells versus the log2
decrease of at least 1.5. Magenta symbols indicate probes associated with a log2 fold-incr
one. The top 150 differentially expressed Affymetrix probes from each normalization al
found to increase in the virus-infected cells are shown in magenta. The number of probe
line represent four genes (BCL2A1, CXXC5, HEIH, TAF1D). The nine probes common for theBJAB cells and over one-third of the KE37 cells (data not shown).
Although viral mRNA could be detected in some of these cultures,
expression of the late hexon and L4 100 K genes was detected in
fewer than 1% of the cells (Furuse et al., 2013) thus conﬁrming the
persistence of viral DNA with minimal ongoing viral replication.
Six independently established infected cell lines (three infected
BJAB and three infected KE37) and six separately maintained mock-
infected cells (three BJAB and three KE37) were used to identify
genes expressed differentially between infected and non-infected
cells using the Affymetrix U133 Plus2.0 microarray. Because the
identiﬁcation of differentially expressed genes is strongly inﬂu-
enced by the normalization method (see Chou et al., 2007; Freyhult
et al., 2010), we selected genes concordantly identiﬁed by four
normalization methods as described in the Materials and Methods.
The relative expression and likelihood of differential expression
between mock- and virus-infected cells is shown for each method
in Fig. 1. As expected, the estimated change in gene expression
varied considerably with each algorithm. For the KE37 cell line, a
log2 cutoff value of 1.5 identiﬁed between 4,874 (Fig. 1C, MAS-5)
and 6 candidate probes (Fig. 1D, SVN). The number of gene probes
differing in expression by a factor of two or more with odds ratio for
differential expression exceeding one was less variable and ranged
from 25 to 62 candidates among the four methods. We selected the
top 150 differentially expressed genes from each normalization
algorithm on the basis of the Bayes-adjusted p-value for differential
expression and identiﬁed probes common to each algorithm. These
results are summarized in the Venn diagrams (Figs. 1E and J). Probes
common to three of four normalization algorithms are reported in
supplementary data (Supplemental Tables S1 and S2).
Only four genes were identiﬁed as differentially expressed
between infected and non-infected T-cells (Fig. 1E). Of these four
genes, one was upregulated (TAF1D) and three (BCL2A1, CXXC5, and
HEIH) were downregulated. Among the four algorithms, the
change in expression for TAF1D varied between 1.6-and 2.4-fold.
Relative expression among the downregulated genes ranged from
a factor of 1.7-to 4.1-fold lower than mock-infected cells. Bys. Gene expression levels were determined after normalization by the four methods
hod was used to calculate a moderated t-statistic for differentially expressed genes
to be 0.4% or about 150 genes. Volcano plots (panels A–D and F–I) display the log of
fold change in gene expression. Green symbols indicate probes with a log2 fold-
ease of at least 1.5. Saturated colors highlight probes with an odds ratio greater than
gorithm are compared in the Venn diagrams in panels E and J. The number of probes
s found to decrease are shown in green. The four probes common for the KE37 cell
BJAB cell line represents six genes (BBS9, BNIP3, BTG3, CXADR, SLFN11, and SPARCL1).
Table 2
Fold-decrease in infected BJAB cells relative to mock-infected cells.
Gene Methoda
qPCR SVN RMA MAS-5 GC-RMA
BBS9 2.1 3.9 4.9 6.8 8.4
BNIP3 2.1 9.0 28 488 2810
BTG3 11.7 5.9 6.9 5.6 17
CXADR 6.4 8.2 14.5 119 6470
SLFN11 8.7 5.6 13.7 10.4 120
SPARCL1 1030 7.2 16.2 320 34
deviationb 0 2.0 2.3 2.8 5.3
a The method used to determine the relative change in gene expression is
indicated.
b The relative deviation from values determined by qPCR is the average mag-
nitude of the difference of the log2-transformed values for all six genes.
Fig. 2. Conﬁrmation of differentially expressed candidate genes from chronically
infected BJAB cells. RNA was isolated from mock-infected and chronically infected
KE37 or BJAB cells and analyzed by qPCR after reverse transcription. The relative
level of expression for the indicated genes compared to mock-infected cells was
determined by the -ΔΔCt method using EIF1 as an endogenous control. The average
change in expression determined in three independent infections is plotted on a
log scale with error bars representing the SD. Levels in virus-infected cells that
were signiﬁcantly different compared to mock-infected cells were identiﬁed with
the t-test applied to the ΔΔCt. (*p-value r 0.05; **p-value r 0.005).
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identiﬁed in B-cells (CXADR, SPARCL1, BNIP3, BTG3, SLFN11, and
BBS9) varied among the four algorithms from four to 6,470-fold
(Table 2). Importantly, the reduction in CXADR (CAR) expression
previously observed in these cells (Zhang et al., 2010) was con-
ﬁrmed by this method.
We focused on evaluating the changes in expression of the six B-
cell associated genes by quantitative PCR after reverse transcription
because these changes were uni-directional and of much larger
magnitude than the T-cell associated gene changes. Among infected
KE37 T-cells, levels of expression for all but BNIP3 were no different
from mock-infected cells (Fig. 2A). The level of BNIP3 mRNA was
slightly higher than in mock-infected T cells (po0.05). In the
infected BJAB B-cells, the level of mRNA for each of the candidate
genes was reduced and this change was signiﬁcant for all but BBS9,
and CD44, which served as a control (Fig. 2B). SPARCL1 expression
decreased the most substantially at over 1000-fold. BTG3, SLFN11
and CXADR (CAR) were the next most decreased, with 11.6-, 8.7-and
6.4-fold reductions, respectively. BBS9 and BNIP3 were reduced by
approximately 2-fold. Although the fold-change in gene expression
determined by microarray typically overestimated that determined
by qPCR, the SVN, RMA and MAS-5 methods reported a similar
pattern among the candidate genes with a comparable overall
deviation compared to qPCR. By this comparison, these methods
were better than the GC-RMA method (Table 2). Overall, these
results reveal that infected lymphocytes are characterized by sur-
prisingly limited changes in gene expression as measured by mRNA
levels and that a greater number and more substantial changes in
gene expression can be detected in the infected B-cell line than the
infected T-cell line used in this study.
3.2. Patterns of coordinately regulated genes in chronically infected
B-and T-cell lines
Strikingly few genes exhibited large differences in expression in
the chronically infected lymphocytic cells. Less dramatic changes in
individual gene expression, however, can occur in a coordinated
manner reﬂecting a molecular signature (see Wang et al., 2008). Six
patterns of genes whose expression differed from non-infected cells
in a coordinated manner were identiﬁed (Fig. 3). The largest group of
coordinately expressed genes (Pattern 1) included 372 gene probes
whose levels were modestly increased in infected KE37 T-cells (red
closed circles), but were unchanged in BJAB B-cells (blue symbols,
Fig. 3A). Conversely, Pattern 2 contained 285 gene probes whose
levels were modestly decreased in infected KE37 cells and largely
unchanged in BJAB cells. However, it appears that for this group, the
corresponding genes were more highly expressed in the infected
cells than non-infected cells (Fig. 3B). Patterns 3 and 4 represent
genes that were unchanged in KE37 cells, but were either modestlyincreased (Pattern 3, 194 gene probes) or decreased (Pattern 4, 114
gene probes) in infected BJAB cells (blue closed squares). Only 43
gene probes were found to be coordinately altered across both
infected B-cell and T-cells, with 22 probes found to increase modestly
in infected lymphocytes (Pattern 5) and 21 probes found to decrease
modestly in infected lymphocytes (Pattern 6). Overall, more than
twice as many probes were coordinately regulated in the chronically
infected T-cell line (657) than in the B-cell line (308).
To determine if these groups of coordinately expressed genes
were biologically related, the Database for Annotation, Visualization
and Integrated Discovery (DAVID) was used to identify functionally
related groups based on gene ontology terms and published gene
annotations (Huang da et al., 2009a, 2009b). The Affymetrix probes
clustered into the six patterns described above were submitted to
the online resource (http://david.abcc.ncifcrf.gov) using a back-
ground of all genes represented on the U133Plus2 microarray.
Seven clusters were identiﬁed among 309 of the 372 probes in
pattern 1, which is elevated in the infected T cell line (Supple-
mental Table S3). None of these genes showed an obvious asso-
ciation with infectious processes. Nine clusters were identiﬁed
from 221 of the 285 probes in pattern 2, which were decreased in
the infected T cell line. Unlike the upregulated genes, two clusters
among these genes suggested a relationship to the biology of an
Fig. 3. Six patterns of coordinately expressed genes are identiﬁed by the EPIG algorithm. (A) Relative mRNA levels determined by the SVN algorithm were used to identify
coordinately expressed genes. Genes from infected cells (closed symbols) are compared with those of mock-infected cells (open symbols) on a log scale. Horizontal lines
indicate the geometric mean for each group of three independent cultures. KE37 T-cells are shown in red, BJAB B-cells in blue. Mean values range from a 1.6-fold increase to a
1.6-fold decrease. (B) The relative changes in all 1008 coordinately expressed genes from each sample are represented by green and magenta for a relative decrease or
increase in virus-infected cells, respectively. Darker colors indicate the lack of differential expression.
D.A. Ornelles et al. / Virology 494 (2016) 67–7772infected lymphocyte. One cluster was involved in programmed cell
death and negative regulation of apoptosis. The other cluster was
associated with the adaptive immune response and lymphocyte
activation.
Among the 194 gene probes that increased in the infected B-
cell line (pattern 3), 148 were mapped to six clusters that included
genes associated with lymphocyte activation, adhesion anddifferentiation. Only two clusters were identiﬁed among the 114
probes in pattern 4 that were downregulated in the B-cell line. The
coxsackie and adenovirus receptor (CXADR) was among these
genes although clustered in a group of three genes associated with
muscle development: CXADR, AFG3L2, and DNER. The stringency
was relaxed in the DAVID algorithm to search for potential clusters
associated with the remaining patterns of 22 and 21 probes;
Fig. 4. Epigenetic repression of CXADR, SPARCL1, SLFN11, and BNIP3 in AdV-infected BJAB
cells is released through inhibition of DNA methyltransferase. Persistently infected BJAB
cells were treated with 300 nM TSA (HDAC Class I & Class II inhibitor), 10 μM 5-AzaC
(DNA methyltransferase inhibitor) for 48 h. Relative quantity of gene message was ana-
lyzed by RT-qPCR. 4-1BBL is shown as a control gene whose expression exhibits little
change in these cell lines and was not signiﬁcantly modulated following infection of
lymphocytic cell lines. Fold-change in gene expression is normalized to a housekeeping
gene and compared to untreated cells (expression set to 1). Error bars represent SD.
Results show the average of two or three independent experiments. Statistical sig-
niﬁcance is indicated for values with three independent measurements (*po0.05; ns,
p40.05).
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enrichment scores less than 1. In total, these results suggest that
infection with adenovirus results in changes in seemingly unre-
lated biological clusters.
To see if the coordinately regulated genes share common
transcriptional regulators, genes identiﬁed in patterns 1 through
4 were analyzed with the Distant Regulatory Elements (Gotea and
Ovcharenko, 2008) or DiRE tool (http://dire.dcode.org/). The
number of genes in patterns 5 and 6 were below the recom-
mended number for analysis. DiRE generates a weighted list of
known regulatory elements based on their abundance in the
promoter, introns and untranslated regions of the target genes
compared to their abundance in a set of 7500 background genes.
Using a relaxed importance cutoff value of 0.275, common reg-
ulatory elements were identiﬁed only for genes downregulated in
KE37 T-cells (pattern 2; VBP, CIZ, FREAC7, and S8) and upregulated
in BJAB B-cells (pattern 3; POLY, S8, HFH3, ICSBP and IRF) (data not
shown). It may be signiﬁcant that these were the only two pat-
terns to have clusters of potential biological signiﬁcance to the
infected cell. These ﬁndings could suggest that coordination of
gene expression in the other patterns of gene expression may
occur through less direct means such as epigenetic modiﬁcation.
3.3. Several Ad-modulated genes appear to be repressed by epige-
netic mechanisms in infected BJAB cells
Although the changes in gene expression following infection
were quite limited, we successfully detected the expected reduction
in CXADR (CAR) expression in infected B-cells with the Affymetrix
microarray. This change, as well as those of ﬁve other genes
downregulated in infected B-cells, was detected 50–70 days post-
infection suggesting that the change persists long after the initial
infection. The long-term loss of CAR expression following infection
was reported to be maintained by epigenetic mechanisms because
treatment with a histone deacetylase inhibitor (HDACi) and a DNA
methyltransferase inhibitor (DNMTi) restored expression of the
gene (Zhang et al., 2010). To determine if expression of the other
genes was down modulated following infection by similar
mechanisms, infected BJAB cells were treated with Trichostatin A
(TSA), an HDACi, or 5-Aza-20-deoxycytidine (5-Aza), a DNMTi.
Expression of the genes of interest was compared between infected
B-cells untreated or treated with TSA alone or 5-Aza alone. As
expected, treatment with the inhibitor of DNMT, 5-Aza, was able to
signiﬁcantly increase expression of CAR. Treatment with TSA alone
for 48 h induced very little change in the expression of any of the
genes (Fig. 4). By contrast, treatment with 5-Aza for 48 h was able
to induce expression of SPARCL1, SLFN11 and BNIP3, but not BTG3 or
BBS9. The expression of 4-1BBL has been reported to be repressed in
human colorectal carcinoma cells by histone de-acetylation (Kumari
et al., 2013), and 4-1BBL expression was robustly increased (18-fold)
in SW620 cells following treatment with TSA as positive control in
our experiments (data not shown). Interestingly, expression of this
gene was not inﬂuenced greatly by HDACi in our human B-cell line
demonstrating that the four genes identiﬁed are speciﬁcally
repressed in our infected cells by these epigenetic mechanisms.
3.4. Similar to infected lymphocytes, childhood leukemic B-cell lines
are refractory to Ad infection
Adenovirus infection inhibits the cell's normal DNA-damage
response (Hart et al., 2005; Karen and Hearing, 2011), potentially
leading to alterations of cellular DNA such as translocations. In a
prior study, cord blood lymphocytes from one donor contained both
high level of adenovirus DNA and a genetic translocation commonly
associated with acute lymphoblastic leukemia (ALL) (Ornelles et al.,
2015). We, and others, have previously speculated that these virusesare candidates for producing the initiating event leading to the
development of childhood acute leukemias (McNally and Eden,
2004; Ornelles et al., 2015). The absence of adenoviral genetic
material in leukemic cells would suggest a potential hit-and-run
mechanism by which the virus permanently alters some cellular
function before being eliminated from the cell. Though we saw
limited changes in gene expression in infected cells we observed a
large effect on subsequent virus infection and infected cells are
refractory to re-infection (Zhang et al., 2010). To determine if cells
derived from ALL shared any characteristics with cells once infected
with adenovirus we evaluated the ability of several diverse leu-
kemic B-cell lines to be infected with adenovirus. A total of 14
human leukemia cell lines were infected and monitored as descri-
bed previously (McNees et al., 2004) for support of the adenovirus
replication cycle (Table 3). Many cell lines (8 of 14, 57%) were pro-
ductively infected with adenovirus as measured by hexon expres-
sion (410% positive) or viral DNA replication. DNA replication
ranged from 43-to 5800-fold (maximum increase above that found
at the time of infection). Productively infected cells contained from
1300 to 176,000 viral genome copies per cell at the peak. The cell
lines in Table 3 have been organized according to their identiﬁed
gene rearrangements and translocation-generated fusion proteins.
Most cell lines (6 of 8; 75%) containing the common translocation-
generated fusion proteins of childhood ALL (TEL-RUNX1, E2A-PBX1,
MLL-AF4, and ENL-MLL) failed to replicate adenovirus. Only two of
the eight cell lines containing common translocations of childhood
acute lymphoblastic leukemia permit adenovirus replication (EU3
and SEM cells). Curiously, almost all of the childhood leukemic cell
lines also did not express surface CAR (7 of 8, 87%). Adenovirus,
however, can infect CAR-negative cells through other receptors such
as the integrins or MHC-I (Cupelli and Stehle, 2011). Accordingly,
productive infections were observed in RPMI-1788 and SB cells,
which are both CAR-negative. Thus the lack of CAR is not the only
barrier to infection (McNees et al., 2004; Zhang et al., 2010).
Table 3
Leukemic B cell lines from children are refractory to adenovirus infection compared
to adult B cell lines.
Cell Line Translocationa Fusion
Geneb
CARc Viral Products
Earlyd Latee DNAf
B cell (childhood)
REH t(12;21)(q13;q22) ETV6-
RUNX1
– – – –
UoC-B4 t(12;21)(q13;q22) ETV6-
RUNX1
– – – –
RS4;11 t(4;11)(q21;q23) MLL-AF4 – þ – –
SEM t(4;11)(q21;q23) MLL-AF4 – þ þ þ
EU-8 t(4;11)(q21;q23) MLL-AF4 – – – –
KOPN-8 t(11;19)(q23;p13) ENL-MLL  þ  
RCH-ACV t(1;19)(q23;p13) E2A-PBX1 – þ – –
697 (EU-3) t(1;19)(q23;p13) E2A-PBX1 Yes þ þ þ
B cell (adult)
ARH77 Unknown None Yes þ þ þ
Ramos Unknown None Yes þ þ þ
RPMI-1788 Unknown None – – þ þ
SB Unknown None – – þ þ
Raji t(8;14)(q24;q32) MYC-IGH Yes þ þ þ
BJAB t(2;8)(p12;q24) IGK-MYC Yes þ þ þ
a Known chromosomal translocation associated with leukemia.
b Leukemic fusion product arising from the chromosomal translocation.
c Cell lines with at least 5% of cells displaying levels of CAR above background
as measured by ﬂow cytometry were considered positive for CAR (yes).
d The ability to direct early gene expression was assessed with an EGFP-
expressing adenovirus vector. Cell lines that showed at least 25% GFP-positive after
infection with the viral vector within 3 dpi were considered permissive for early
gene expression (þ).
e The ability to direct late gene expression was assessed by infection with a
wild-type virus. Cell lines with at least 30% hexon-positive cells measured within
3 dpi by ﬂow cytometry were considered permissive for late gene expression
(þ).
f Cell lines that ampliﬁed viral DNA by at least 4-fold over input levels following
infection with the wild-type virus were considered to support viral DNA replication
(þ).
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not required, nor is it sufﬁcient, to support virus replication and
gene expression in human leukemia cell lines. Interestingly, all of
the adult derived leukemic cell lines were able to support DNA
replication and late gene expression, regardless of surface CAR
expression. Overall, we found that while adult derived cell lines
could support viral infection, very few of the childhood derived cell
lines could support infection. These ﬁndings lead us to hypothesize
that certain proteins associated with childhood ALL, such as ETV6-Fig. 5. Two of the six genes repressed in AdV-infected cells show signiﬁcantly reduced
Relative mRNA levels comparing adult and childhood leukemic lines were determined an
SPARCL1 could not be detected in the childhood leukemic cell lines. For these cases, the m
to determine if the mean level for each gene in the childhood leukemic cell lines (blue) w
value of less than 0.05 was considered signiﬁcant. Because the Ct was assigned a limiti
estimate. The fold-change shown for these values (indicated with a break in the bar) reRUNX1, limit the outcome of an adenovirus infection in
lymphocytic cells.
3.5. CAR expression is repressed in childhood leukemic cell lines as
compared to adult leukemic cell lines
To determine if other changes associated with adenovirus-
infected B-lymphocytes were present in childhood leukemic cells
we evaluated expression of the six identiﬁed “ﬁngerprint” genes
between childhood and adult derived leukemic cells. Two of the
six genes repressed in Ad-infected B cells, CXADR (CAR) and
SPARCL1, also were signiﬁcantly repressed in childhood leukemic
cell lines as compared to adult leukemic cell lines (Fig. 5). No
discernable pattern of expression that could be segregated by
childhood versus adult origin was observed for the other four
genes (SLFN11, BBS9, BNIP3 or BTG3).
Because the expression of several of these genes appears to be
reduced by epigenetic mechanisms following infection of B-cells
with adenovirus we also sought to determine if these genes were
epigenetically repressed in leukemic cell lines. Both adult (ARH77
and BJAB) and child leukemic cell lines (UOC-B4, RS4;11, and KOPN-
8) were treated with TSA or 5-Aza for 48 h. For all cell lines except
UOC-B4, viability was above 90% during 48-h treatment with
300 nM TSA. UOC-B4 cells were more sensitive to the drug and
were instead treated with 50 nM TSA (Busbee et al., 2014) to
maintain viability above 90% during treatment (data not shown).
Treatment of childhood cell lines with DNMTi caused a robust
increase in CXADR expression (200-fold; RS4;11 and 137-fold; UoC-
B4 and 183-fold; KOPN-8) in the childhood cell lines (Table 4) as
compared to changes occurring in both adult cell lines (r1.5-fold).
In fact, CXADR expression, which was undetectable in untreated
RS4;11 cells, was only detectable after 5-Aza treatment. SPARCL1
shows similar upregulation after DNMTi treatment of the childhood
derived cell line RS4;11 only (36-fold) but not as robustly in the
other childhood lines (UoCB4; 2.6-fold change and KOPN; 2.8-fold)
(Table 4). SPARCL1 was, however, moderately upregulated following
DNMTi in the adult cell line BJAB (7-fold). There was some response
to HDACi among the childhood cell lines. UoC-B4 and KOPN-8 cells
responded to TSA-treatment by increased expression of CXADR, and
RS4;11 cells upregulated SPARCL expression. However, expression of
these genes appeared to be much more sensitive to treatment with
the DNMTi 5-Aza than to treatment with the HDACi TSA. By con-
trast, BTG3 showed no evidence of epigenetic repression similar to
infected B cells (Fig. 4). The other three target genes (SLFN11, BNIP3,
and BBS9) showed evidence of epigenetic regulation, but noexpression in childhood leukemic cell lines compared to adult leukemic cell lines.
d are plotted as a fold-change (2ΔΔCt). In some experiments, mRNA for CXADR and
RNA level was set to a limiting value determined by a Ct of 40. The t-test was used
as signiﬁcantly different the mean level for the adult cell lines (yellow/orange). A p-
ng value in certain cases, p-values for CXADR and SPARCL1 must be considered an
presents an upper limit.
Table 4
CXADR and SPARCL expression is epigenetically regulated in childhood leukemic cell
linesa.
Gene Fold-change relative to untreated cellsb
Treatmentc Cell line
ARH77 BJAB UoC-B4 RS4;11 KOPN-8
CXADR TSA 1.2 1.4 24.1 1.2 3.2
AzaC 1.5 1.2 137.3 199 183
SPARCL TSA 1.4 1.1 1.7 6.8 1.4
AzaC 2.3 6.9 2.6 36.3 2.8
BTG3 TSA 0.9 1.1 1 1.2 0.97
AzaC 1.8 1.5 1.1 6.1 0.94
a Total cellular RNA was isolated from cells that were untreated, treated with
TSA or 5-AzaC for 48 h.
b Relative levels of mRNA for the indicated gene were measured by RT-qPCR
and are expressed relative to the level measured in untreated cells for each
cell line.
c TSA was used at 50 nM for UoC-B4 cells and 300 nM for all other cell lines.
5-AzaC was used at a 10 uM.
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lines was observed (data not shown). These data suggest that CAR
expression is robustly repressed by epigenetic means in childhood
leukemic cell lines as compared to adult leukemic cell lines.4. Conclusions
Adenovirus is a DNA tumor virus with the ability to transform and
immortalize rodent cells (Nevels et al., 2001) and immortalize primary
human cells of neural origin (Arnhold et al., 2008; Fallaux et al., 1996;
Shaw et al., 2002) in culture. However, unlike other human DNA
tumor viruses, adenovirus has not been shown to be the cause of any
human cancer. However, adenovirus is similar to another DNA tumor
virus EBV by its ability to persist in lymphocytic cells. EBV establishes a
latent infection in memory B cells and can transform peripheral blood
B cells into immortalized lymphoblastoid cells (Speck and Ganem,
2010). Changes in cellular gene expression provoked by EBV have been
well-characterized during type I and III latent infections, which pre-
cedes transformation into lymphoblastic cells (Speck and Ganem,
2010). These changes include decreased expression of tumor sup-
pressor genes and increased expression of growth promoting genes
(Fukayama et al., 2008; Klein et al., 2010; Niller et al., 2009). Several
adenovirus genes are well known for their ability to alter the
expression or activity of these classes of cellular genes (Vink et al.,
2015; Zhao et al., 2007). Consequently, one focus of this study was to
evaluate gene expression in lymphocytic cells infected persistently
with species C adenovirus and in order to identify changes that could
contribute to oncogenesis.
Lymphocytes infected with species C adenoviruses survive and
continue to proliferate at rates similar to uninfected cells (Zhang et
al., 2010). Lymphocytic cells display little of the cytopathic effect
that characterizes infected epithelial cells despite carrying as many
as 100,000 copies of the viral genome while growing in culture.
Despite such a heavy viral burden, the breadth of change in cellular
gene expression in these cells is surprisingly limited. By microarray,
we found six genes in the B-cell line (BJAB) and four genes in the T-
cell line (KE37) that were differentially expressed in the persistently
infected cells (Fig. 1). We consider these to be durable changes
because they were detected in cells 50–80 days after initial infec-
tion and at a time when viral gene expression was virtually absent
in most cells. Curiously, the genes modulated in the B cell line all
exhibited decreased expression. Moreover, downregulation of CAR
was conﬁrmed as has been previously reported (Zhang et al., 2010).The four different normalization methods used here identiﬁed a
range of 33 and 35 candidate genes differing in expression by a
factor of two for BJAB and KE37 cells, respectively (Supplemental
Table S1 and S2). The range of the changes observed in lymphocytes
harboring an apparently latent infection with adenovirus is com-
parable to that reported for other DNA viruses (Homa et al., 2013;
Slobedman et al., 2004). For example, Slobedman et al., reported
that 35 host genes changed expression in cells latently infected with
CMV (Slobedman et al., 2004) and a study by Hoever et al., found 11
host genes changed by latent CMV infection (Hoever et al., 2005).
Carter et al., (2002) reported 38 host RNAs were consistently two-
fold more abundant in the EBV-positive lymphoblastic cell lines
when compared to EBV-negative Burkitt's lymphoma by microarray
analysis. In contrast to other studies that typically use a single
algorithm to identify differentially expressed genes, we chose to
increase the rigor of our analysis by applying four different algo-
rithms. By this approach, we identiﬁed only six differentially
expressed genes (Table 2). Nonetheless, each algorithm identiﬁed
additional and different genes (Supplemental Table S1 and S2). The
RMA algorithm identiﬁed 20 and 16 differentially expressed genes
in infected BJAB cells and KE37 cells, respectively. The MAS
approach identiﬁed 19 genes in infected BJAB cells and 12 in
infected KE37 cells. In addition to determining the changes in gene
expression deﬁned by the magnitude of the gene, we also searched
for patterns of coordinately regulated genes in chronically infected
B-and T-cell lines (Fig. 3). The more biologically suggestive clusters
in the KE37 T-cell line were identiﬁed among the downregulated
genes. These genes seem to be related to the infectious process in
lymphocytes and were related to programmed cell death, the
adaptive immune response and lymphocyte activation. By contrast,
the more biologically suggestive clusters in the infected BJAB B-cell
line were found among the upregulated genes, which were loosely
associated with lymphocyte activation. Very few coordinately
regulated genes were identiﬁed for both types of lymphocytes
(Fig. 3, pattern 5 and 6) and no signiﬁcant functional clusters were
found among these few genes (data not shown). The apparently
unrelated nature of coordinately regulated genes also has been
observed for many of the differentially expressed genes identiﬁed in
herpesvirus-infected cells (Carter et al., 2002; Price et al., 2012).
The changes in cellular gene expression reported here persist
for many cell divisions. EBV also elicits epigenetic changes in the
host cell genome (Leonard et al., 2011; Niller et al., 2014) that are
retained for several cell generations. We found that of the six
genes down regulated in infected B cells, four were under epige-
netic control by methylation because treatment with an inhibitor
of DNA methyltransferase restored expression (Fig. 4). Further
methylation appeared to be the dominant mechanism of gene
repression when compared to acetylation mechanisms. Adenoviral
proteins such as E1A (Ferrari et al., 2012; Horwitz et al., 2008) and
E4-ORF3 (Soria et al., 2010) have both been reported to induce
epigenetic changes in infected cells. Further, the E1A promoter
itself is subject to methylation (Hsu et al., 2010). CXADR has been
reported to be epigenetically repressed in virally infected lym-
phocytes (Zhang et al., 2010) and epigenetically regulated in other
cells (Pong et al., 2003). BNIP3, which is silenced by epigenetic
mechanisms in several malignant epithelial cell lines (Bacon et al.,
2007), was the most robustly de-repressed gene following treat-
ment with DNMTi. Interestingly, although not much is known
about the function of the other two epigenetically regulated genes
they both are associated with cancer. Secreted protein acidic and
rich in cysteines-like protein 1 (SPARCL1) is an extracellular matrix
glycoprotein that has been implicated in the pathogenesis of
several disorders including cancer. The downregulation of SPARCL1
was correlated with lymphatic metastasis and poor tumor grade in
breast cancer (Cao et al., 2013) as well as increased metastatic
potential in prostate cancer (Xiang et al., 2013). Schlafen-11
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nocarcinoma and colon adenocarcinoma was reduced compared to
that in normal tissues (Zoppoli et al., 2012).
It is estimated that viruses contribute to approximately 15% of
human cancers (Butel, 2000) and an infectious etiology for ALL has
been widely supported (Einav et al., 2005; Heath, 2005; McNally and
Eden, 2004). Because several of the genes downregulated in infected
B cells have been associated with other cancers, we sought to
determine how similar adenovirus-infected B cells were to leukemic
B cells from ALL. We found that leukemic cells derived from child-
hood leukemia were refractory to adenovirus infection in a manner
similar to once-infected BJAB cells (Table 3). B cells derived from
adult leukemias were much more susceptible to infection. Because
the six genes we identiﬁed as downregulated in infected B cells were
repressed long after infection with adenovirus, we evaluated the
expression of these genes in leukemic B cells. Two of the six genes,
CXADR and SPARCL1, were indeed downregulated in childhood leu-
kemic cells (Fig. 5). In addition, CXADR expression was epigenetically
repressed across the childhood leukemic cell lines (Table 4). Similar
to infected B cells, gene expression was most robustly increased
following treatment with an inhibitor of DNMT. CAR is a cellular
adhesion protein that is used by adenovirus to gain entrance to the
cell (Cupelli and Stehle, 2011). Downregulation and reduced
expression of this gene understandably prevents adenovirus from
entering cells. However, forced re-expression of this gene does not
allow re-infection (Zhang et al., 2010), suggesting that other changes
must restrict virus replication. In addition to being a negative reg-
ulator of cell growth and proliferation that is downregulated in a
number of cancers (Claeskens et al., 2000; Sullivan and Sage, 2004),
SPARCL1 (also known as HEVIN and SC1/ECM1) encodes an extra-
cellular matrix glycoprotein that is highly expressed during embry-
ogenesis (Sullivan and Sage, 2004). We have not yet determined if
enforced expression of SPARCL1 is sufﬁcient to restore susceptibility
to infection with adenovirus. Because SPARCL1 has been shown to
augment the proliferation of B cells in response to mitogens (Oritani
et al., 1997), downregulation of this gene may contribute to the
persistence of adenovirus in these B cells, but may also be involved in
the malignancy of the childhood leukemic cell lines.Acknowledgments
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